JPRN-UMIN000017560
Completed
未知
Study of the effectiveness of the response and interferon combination therapy for ribavirin monotherapy for chronic hepatitis C - Study of the response of ribavirin monotherapy in patients with chronic hepatitis C
ConditionsChronic hepatitis C
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Chronic hepatitis C
- Sponsor
- Hokkaido University
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •We excluded: 1\)HBs antibody positive 2\))HIV antibody positive 3\)decompensated liver chirrosis 4\)severe herat failuer 5\)severe kideny dysfunction 6\)ineligible to interferon therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A study on the efficacy of the loss of response to jaw thrust as a clinical test to assess adequate depth of anesthesia using remimazolam besylate and the dose required for the loss of response.JPRN-jRCT1031210554Okuda Yasuhisa70
Not yet recruiting
Phase 3
Evaluation of the response and adverse effects of total neoadjuvant therapy (TNT) of advanced localized rectal cancerC18.7Rectal cancer.Malignant neoplasm of sigmoid colonIRCT20120215009014N431Hamedan University of Medical Sciences25
Recruiting
Not Applicable
The effectiveness of positive intervention on psychological well - being The effectiveness of positive intervention on resilience The effectiveness of positive intervention on quality of lifeThe effectiveness of positivist intervention on psychological well-being the effectiveness of positivist intervention reflect the effectiveness of positivist intervention on quality of life.IRCT20201007048968N1Mashhad University of Medical Sciences53
Completed
Not Applicable
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK)ot applicableJPRN-UMIN000051748Suntory Wellness Limited200
Active, not recruiting
Not Applicable
Assessment of the early efficacy response rate of leflunomide according to the initial dosing regimen in the treatment of naive - DMARD early RA-patients. - LEADERPatients with a diagnosis of early active rhematoid arthritis in the previous 6 months, naive of previous treatment by DMARD and who need to be treated by DMARD.MedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2007-000886-40-ITsanofi-aventis Groupe200